ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

PACIFIC-R: Findings Reflect Clinical Reality of Consolidation Therapy in Stage III NSCLC

Leah Lawrence
on: April 23, 2021In: Meeting News
PACIFIC-R: Findings Reflect Clinical Reality of Consolidation Therapy in Stage III NSCLC

  The real-world assessment of durvalumab in patients with unresectable stage III NSCLC in the PACIFIC-R trial has highlighted important differences between this population and that of the original randomized […] Read more


Symposium Chairs Reflect on Current Status, Next Steps for Lung Cancer Screening on a Global Scale

Joy Curzio
on: April 22, 2021In: Meeting News
Symposium Chairs Reflect on Current Status, Next Steps for Lung Cancer Screening on a Global Scale

It has been documented and accepted that lung cancer screening saves lives by detecting disease in high-risk individuals at earlier stages, making the disease more treatable and leading to improved […] Read more

The “Holy Grail” of Lung Cancer Research: Bring the Immune System into Every Tumor

Johan Vansteenkiste
on: March 30, 2021In: Meeting News
The “Holy Grail” of Lung Cancer Research: Bring the Immune System into Every Tumor

With multiple new therapies available, Prof. Johan Vansteenkiste says the search is on for biomarkers to better match patients to treatments. Read more

Could the Daunting Biology of Small-Cell Lung Cancer Provide the Key to Elucidating Drug Resistance?

Fiona Blackhall
on: March 30, 2021In: Meeting News
Could the Daunting Biology of Small-Cell Lung Cancer Provide the Key to Elucidating Drug Resistance?

At ELCC 2021, Prof. Fiona Blackhall sees hope for improving patients’ poor prognoses on the horizon. Read more

Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604

Urania Dafni, ScD
+more
on: January 11, 2021In: Meeting News
Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604

In the era of targeted treatments and immunotherapies, it is relatively common to address multiple questions in a single phase III clinical trial. These questions often involve using more than […] Read more

University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American Oncologists for 3-Day Preceptorship 

David R. Gandara
on: October 19, 2020In: Meeting News
University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American
            Oncologists for 3-Day Preceptorship 

David R. Gandara, MD, past-president of the IASLC and director of Thoracic Oncology and senior advisor, UC Davis Comprehensive Cancer Center (UCDCCC), has always had a passion for mentorship, largely […] Read more

Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring

Kara Nyberg, PhD
on: October 09, 2020In: Meeting News
Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring

Although cell-free DNA (cfDNA) has emerged as the favored nucleic acid to analyze in liquid biopsy samples, there are situations when this marker fails to provided necessary information. In such cases, cell-free RNA (cfRNA) might help […] Read more

Supporting the Detection of Early-Stage Disease with Use of Biomarkers

Kara Nyberg, PhD
on: October 09, 2020In: Meeting News
Supporting the Detection of Early-Stage Disease with Use of Biomarkers

The NELSON trial and the US National Lung Cancer Screening Trial (NLST) marked major advances in lung cancer by establishing that low-dose computed tomography (LDCT) screening of high-risk individuals is effective at catching the disease in early […] Read more

Leveraging ctDNA to Detect Minimal Residual Disease Following Surgery

Kara Nyberg, PhD
on: October 09, 2020In: Meeting News
Leveraging ctDNA to Detect Minimal Residual Disease Following Surgery

Curative therapy remains elusive in early-stage NSCLC following surgical resection, sometimes even for patients with stage I disease. Adjuvant therapy can be of benefit, but only for a select few. As shown in the Lung Adjuvant […] Read more

ctDNA Offers a Window Into Emerging Mechanisms of Resistance to Targeted Therapy

Kara Nyberg, PhD
on: October 09, 2020In: Meeting News
ctDNA Offers a Window Into Emerging Mechanisms of Resistance to Targeted Therapy

Targeted therapy has undoubtedly transformed the treatment landscape for metastatic NSCLC, with multiple agents now available to target seven different molecular drivers. In tandem with the growing treatment armamentarium, comprehensive molecular profiling has been critical in providing insight […] Read more

«‹17181920212223›»
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy